TP53 and neoplasm: Supporting this assumption, we found that 8 out of 9 (89%) tumours with an EGFR copy number increase harboured a TP53 mutation whereas a TP53 mutation was found in 22 out of 38 (56%) tumours without detectable EGFR copy number increase.